WO2025041034 - PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN LAYER 5 CELLS IN MOUSE CORTEX
National phase entry is expected:
Publication Number
WO/2025/041034
Publication Date
27.02.2025
International Application No.
PCT/IB2024/058072
International Filing Date
20.08.2024
Title **
[English]
PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN LAYER 5 CELLS IN MOUSE CORTEX
[French]
PROMOTEUR POUR L'EXPRESSION SPÉCIFIQUE DE GÈNES DANS DES CELLULES DE COUCHE 5 DANS UN CORTEX DE SOURIS
Applicants **
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH
Inventors
KELLER, Georg
SAENZ DE BURUAGA CORROCHANO, Beatriz Lucia
Priority Data
23192647.8
22.08.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1938 | |
| EPO | Filing, Examination, Granting | 8126 | |
| Japan | Filing, Examination, Granting | 2062 | |
| South Korea | Filing, Examination, Granting | 1883 | |
| USA | Filing, Examination, Granting | 7140 |
Total:
21,149
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention provides an isolated nucleic acid molecule comprising, or consisting of, the nucleic acid sequence of SEQ ID NO:1 or of a nucleic acid sequence of at least 1400 bp having at least 80% identity to said sequence of SEQ ID NO:1, wherein said isolated nucleic acid molecule leads to the specific expression of an exogenous gene in layer 5 cells in mouse cortex when a nucleic acid sequence coding for said exogenous gene is operatively linked to said isolated nucleic acid molecule.[French]
La présente invention concerne une molécule d'acide nucléique isolée comprenant, ou consistant en, la séquence d'acide nucléique de SEQ ID NO : 1 ou d'une séquence d'acide nucléique d'au moins 1400 pb ayant au moins 80% d'identité avec ladite séquence de SEQ ID NO : 1, ladite molécule d'acide nucléique isolée conduisant à l'expression spécifique d'un gène exogène dans les cellules de couche 5 dans le cortex de souris lorsqu'une séquence d'acide nucléique codant pour ledit gène exogène est liée de manière fonctionnelle à ladite molécule d'acide nucléique isolée.